Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization: A report from the Children's Oncology Group

Kristi J. Smock, Marilu Nelson, Sheryl R. Tripp, Warren G. Sanger, Minnie Abromowitch, Mitchell S. Cairo, Sherrie L. Perkins

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. T-lymphoblastic lymphoma (T-LBL) accounts for 25-30% of childhood non-Hodgkin's lymphoma and is closely related to T-lymphoblastic leukemia (T-ALL). Recently, we demonstrated distinct differences in gene expression between childhood T-LBL and T-ALL, but molecular pathogenesis and relevant protein expression patterns in T-LBL remain poorly understood. Procedure. Children with T-LBL with disseminated disease were registered and treated on COG protocol 5971. Paraffin-embedded tumor tissue was obtained at diagnosis for immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) studies. We determined the pattern and intensity of staining for c-Myc, Skp2, Mib-1, p53, TCL-1, bcl-2, and bcl-6 proteins by IHC and c-Myc, p53, bcl-2, bcl-6, and TCR α/δ molecular alterations by FISH in 22 pediatric T-LBL cases. Results. The majority of T-LBL samples expressed Mib-1 (59%) and c-Myc (77%) proteins in greater than 50% of the cells, but Skp2 (14%), p53 (14%), and bcl-2 (23%) expression was less common. FISH studies demonstrated 18% gains and 10% losses in c-Myc, 16% gains in p53, 12% gains and 6% losses in bcl-2, and 6% gains and 19% losses in bcl-6 with little direct correlation between the IHC and FISH studies. Conclusions. Childhood T-LBL is a highly proliferative tumor associated with enhanced expression of c-Myc protein, but without detectable c-Myc molecular alterations. FISH studies did not identify consistent etiologies of molecular dysregulation, and future studies with other molecular approaches may be required to elucidate the molecular pathogenesis of childhood T-LBL.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalPediatric Blood and Cancer
Volume51
Issue number4
DOIs
StatePublished - Oct 1 2008

Fingerprint

Fluorescence In Situ Hybridization
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Proto-Oncogene Proteins c-myc
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Immunohistochemistry
Proto-Oncogene Proteins c-bcl-6
Paraffin
Non-Hodgkin's Lymphoma
Neoplasms
Pediatrics
Staining and Labeling
Gene Expression

Keywords

  • Fluorescence in situ hybridization
  • Immunohistochemistry
  • Immunophenotyping
  • Molecular analysis
  • T-cell lymphoblastic lymphoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization : A report from the Children's Oncology Group. / Smock, Kristi J.; Nelson, Marilu; Tripp, Sheryl R.; Sanger, Warren G.; Abromowitch, Minnie; Cairo, Mitchell S.; Perkins, Sherrie L.

In: Pediatric Blood and Cancer, Vol. 51, No. 4, 01.10.2008, p. 489-494.

Research output: Contribution to journalArticle

Smock, Kristi J. ; Nelson, Marilu ; Tripp, Sheryl R. ; Sanger, Warren G. ; Abromowitch, Minnie ; Cairo, Mitchell S. ; Perkins, Sherrie L. / Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization : A report from the Children's Oncology Group. In: Pediatric Blood and Cancer. 2008 ; Vol. 51, No. 4. pp. 489-494.
@article{a4cebc6a1e5f40ddadd39eaa3769686b,
title = "Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization: A report from the Children's Oncology Group",
abstract = "Background. T-lymphoblastic lymphoma (T-LBL) accounts for 25-30{\%} of childhood non-Hodgkin's lymphoma and is closely related to T-lymphoblastic leukemia (T-ALL). Recently, we demonstrated distinct differences in gene expression between childhood T-LBL and T-ALL, but molecular pathogenesis and relevant protein expression patterns in T-LBL remain poorly understood. Procedure. Children with T-LBL with disseminated disease were registered and treated on COG protocol 5971. Paraffin-embedded tumor tissue was obtained at diagnosis for immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) studies. We determined the pattern and intensity of staining for c-Myc, Skp2, Mib-1, p53, TCL-1, bcl-2, and bcl-6 proteins by IHC and c-Myc, p53, bcl-2, bcl-6, and TCR α/δ molecular alterations by FISH in 22 pediatric T-LBL cases. Results. The majority of T-LBL samples expressed Mib-1 (59{\%}) and c-Myc (77{\%}) proteins in greater than 50{\%} of the cells, but Skp2 (14{\%}), p53 (14{\%}), and bcl-2 (23{\%}) expression was less common. FISH studies demonstrated 18{\%} gains and 10{\%} losses in c-Myc, 16{\%} gains in p53, 12{\%} gains and 6{\%} losses in bcl-2, and 6{\%} gains and 19{\%} losses in bcl-6 with little direct correlation between the IHC and FISH studies. Conclusions. Childhood T-LBL is a highly proliferative tumor associated with enhanced expression of c-Myc protein, but without detectable c-Myc molecular alterations. FISH studies did not identify consistent etiologies of molecular dysregulation, and future studies with other molecular approaches may be required to elucidate the molecular pathogenesis of childhood T-LBL.",
keywords = "Fluorescence in situ hybridization, Immunohistochemistry, Immunophenotyping, Molecular analysis, T-cell lymphoblastic lymphoma",
author = "Smock, {Kristi J.} and Marilu Nelson and Tripp, {Sheryl R.} and Sanger, {Warren G.} and Minnie Abromowitch and Cairo, {Mitchell S.} and Perkins, {Sherrie L.}",
year = "2008",
month = "10",
day = "1",
doi = "10.1002/pbc.21666",
language = "English (US)",
volume = "51",
pages = "489--494",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Characterization of childhood precursor T-lymphoblastic lymphoma by lmmunophenotyping and fluorescent in situ hybridization

T2 - A report from the Children's Oncology Group

AU - Smock, Kristi J.

AU - Nelson, Marilu

AU - Tripp, Sheryl R.

AU - Sanger, Warren G.

AU - Abromowitch, Minnie

AU - Cairo, Mitchell S.

AU - Perkins, Sherrie L.

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Background. T-lymphoblastic lymphoma (T-LBL) accounts for 25-30% of childhood non-Hodgkin's lymphoma and is closely related to T-lymphoblastic leukemia (T-ALL). Recently, we demonstrated distinct differences in gene expression between childhood T-LBL and T-ALL, but molecular pathogenesis and relevant protein expression patterns in T-LBL remain poorly understood. Procedure. Children with T-LBL with disseminated disease were registered and treated on COG protocol 5971. Paraffin-embedded tumor tissue was obtained at diagnosis for immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) studies. We determined the pattern and intensity of staining for c-Myc, Skp2, Mib-1, p53, TCL-1, bcl-2, and bcl-6 proteins by IHC and c-Myc, p53, bcl-2, bcl-6, and TCR α/δ molecular alterations by FISH in 22 pediatric T-LBL cases. Results. The majority of T-LBL samples expressed Mib-1 (59%) and c-Myc (77%) proteins in greater than 50% of the cells, but Skp2 (14%), p53 (14%), and bcl-2 (23%) expression was less common. FISH studies demonstrated 18% gains and 10% losses in c-Myc, 16% gains in p53, 12% gains and 6% losses in bcl-2, and 6% gains and 19% losses in bcl-6 with little direct correlation between the IHC and FISH studies. Conclusions. Childhood T-LBL is a highly proliferative tumor associated with enhanced expression of c-Myc protein, but without detectable c-Myc molecular alterations. FISH studies did not identify consistent etiologies of molecular dysregulation, and future studies with other molecular approaches may be required to elucidate the molecular pathogenesis of childhood T-LBL.

AB - Background. T-lymphoblastic lymphoma (T-LBL) accounts for 25-30% of childhood non-Hodgkin's lymphoma and is closely related to T-lymphoblastic leukemia (T-ALL). Recently, we demonstrated distinct differences in gene expression between childhood T-LBL and T-ALL, but molecular pathogenesis and relevant protein expression patterns in T-LBL remain poorly understood. Procedure. Children with T-LBL with disseminated disease were registered and treated on COG protocol 5971. Paraffin-embedded tumor tissue was obtained at diagnosis for immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) studies. We determined the pattern and intensity of staining for c-Myc, Skp2, Mib-1, p53, TCL-1, bcl-2, and bcl-6 proteins by IHC and c-Myc, p53, bcl-2, bcl-6, and TCR α/δ molecular alterations by FISH in 22 pediatric T-LBL cases. Results. The majority of T-LBL samples expressed Mib-1 (59%) and c-Myc (77%) proteins in greater than 50% of the cells, but Skp2 (14%), p53 (14%), and bcl-2 (23%) expression was less common. FISH studies demonstrated 18% gains and 10% losses in c-Myc, 16% gains in p53, 12% gains and 6% losses in bcl-2, and 6% gains and 19% losses in bcl-6 with little direct correlation between the IHC and FISH studies. Conclusions. Childhood T-LBL is a highly proliferative tumor associated with enhanced expression of c-Myc protein, but without detectable c-Myc molecular alterations. FISH studies did not identify consistent etiologies of molecular dysregulation, and future studies with other molecular approaches may be required to elucidate the molecular pathogenesis of childhood T-LBL.

KW - Fluorescence in situ hybridization

KW - Immunohistochemistry

KW - Immunophenotyping

KW - Molecular analysis

KW - T-cell lymphoblastic lymphoma

UR - http://www.scopus.com/inward/record.url?scp=50249170951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249170951&partnerID=8YFLogxK

U2 - 10.1002/pbc.21666

DO - 10.1002/pbc.21666

M3 - Article

C2 - 18618503

AN - SCOPUS:50249170951

VL - 51

SP - 489

EP - 494

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -